PT Millennium Pharmacon International Tbk (ISX:SDPC) Cyclically Adjusted Revenue per Share: Rp2,875.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SDPC PT Millennium Pharmacon International Tbk ISX:SDPC
79 GF Score
Price Rp181.00
GF Value Rp166.83
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is PT Millennium Pharmacon International Tbk Cyclically Adjusted Revenue per Share?

PT Millennium Pharmacon International Tbk ISX:SDPC 79 Cyclically Adjusted Revenue per Share is Rp2,875.25 as of Mar. 2026. GuruFocus rates ISX:SDPC with a GF Score™ of 79/100 and a GF Value™ of Rp166.83 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PT Millennium Pharmacon International Tbk's adjusted revenue per share for the three months ended in Mar. 2026 was Rp799.037. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is Rp2,875.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, PT Millennium Pharmacon International Tbk's average Cyclically Adjusted Revenue Growth Rate was 3.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of PT Millennium Pharmacon International Tbk was 3.10% per year. The lowest was 3.10% per year. And the median was 3.10% per year.

As of today (2026-08-01), PT Millennium Pharmacon International Tbk's current stock price is Rp181.00. PT Millennium Pharmacon International Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was Rp2,875.25. PT Millennium Pharmacon International Tbk's Cyclically Adjusted PS Ratio of today is 0.06.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Millennium Pharmacon International Tbk was 0.14. The lowest was 0.04. And the median was 0.05.


PT Millennium Pharmacon International Tbk  (ISX:SDPC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PT Millennium Pharmacon International Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=181.00/2875.25
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Millennium Pharmacon International Tbk was 0.14. The lowest was 0.04. And the median was 0.05.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PT Millennium Pharmacon International Tbk Cyclically Adjusted Revenue per Share Related Terms


PT Millennium Pharmacon International Tbk Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for PT Millennium Pharmacon International Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Millennium Pharmacon International Tbk Cyclically Adjusted Revenue per Share Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2,606.23 2,675.28 2,757.55 2,854.44

PT Millennium Pharmacon International Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,772.57 2,797.98 2,818.06 2,854.44 2,875.25

ISX:SDPC vs MCK, COR, CAH: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Cyclically Adjusted PS Ratio falls into.


ISX:SDPC
79GF Score
PT Millennium Pharmacon International Tbk ISX:SDPC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Millennium Pharmacon International Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Millennium Pharmacon International Tbk's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=799.037/136.5387*136.5387
=799.037

Current CPI (Mar. 2026) = 136.5387.

PT Millennium Pharmacon International Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 696.057 103.212 920.808
201609 635.192 104.142 832.786
201612 678.434 105.222 880.354
201703 689.777 106.476 884.531
201706 668.430 107.722 847.246
201709 746.951 108.020 944.152
201712 431.292 109.017 540.174
201803 622.956 110.097 772.573
201806 440.570 111.085 541.522
201809 436.537 111.135 536.325
201812 394.065 112.430 478.566
201903 532.095 112.829 643.911
201906 523.092 114.730 622.524
201909 535.675 114.905 636.531
201912 549.448 115.486 649.611
202003 616.390 116.252 723.952
202006 443.272 116.630 518.939
202009 471.422 116.397 553.000
202012 543.976 117.318 633.097
202103 536.726 117.840 621.894
202106 584.484 118.184 675.259
202109 661.702 118.262 763.966
202112 563.123 119.516 643.328
202203 638.506 120.948 720.811
202206 576.468 123.322 638.247
202209 663.666 125.298 723.202
202212 633.788 126.098 686.266
202303 591.513 126.953 636.178
202306 637.895 127.663 682.245
202309 685.656 128.151 730.531
202312 725.060 129.395 765.091
202403 764.311 130.607 799.023
202406 758.676 130.792 792.013
202409 772.234 130.361 808.830
202412 779.241 131.432 809.521
202503 769.378 131.948 796.144
202506 755.491 133.241 774.192
202509 831.627 133.819 848.529
202512 869.416 135.271 877.563
202603 799.037 136.539 799.037

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of Rp2,875.25 mean?
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a Cyclically Adjusted Revenue per Share of Rp2,875.25 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PT Millennium Pharmacon International Tbk and its competitors.
Is PT Millennium Pharmacon International Tbk's Cyclically Adjusted Revenue per Share too high?
PT Millennium Pharmacon International Tbk's current Cyclically Adjusted Revenue per Share is Rp2,875.25. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's Cyclically Adjusted Revenue per Share compare to MCK and COR?
PT Millennium Pharmacon International Tbk's Cyclically Adjusted Revenue per Share of Rp2,875.25 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on PT Millennium Pharmacon International Tbk and its competitors. PT Millennium Pharmacon International Tbk's current Cyclically Adjusted Revenue per Share is Rp2,875.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is Rp2,875.25. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current Cyclically Adjusted Revenue per Share is Rp2,875.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?

Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued. The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83. GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.

Key valuation signals for ISX:SDPC:

  • Cyclically Adjusted Revenue per Share: Rp2,875.25
  • GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Millennium Pharmacon International Tbk Business Description

Address Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score

Get the complete analysis for ISX:SDPC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp181.00
Price
Rp166.83
GF Value